Item Type | Name |
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Epithelial Cells
|
Concept
|
Neoplasms, Squamous Cell
|
Academic Article
|
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
Head and neck cancer.
|
Academic Article
|
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
|
Academic Article
|
DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy.
|
Academic Article
|
Differential retention of tumor- and differentiation-suppressor functions in cells derived from a human squamous cell carcinoma.
|
Academic Article
|
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
|
Academic Article
|
Phosphorous metabolite and cell cycle kinetic response of two human squamous cell carcinomas to radiation.
|
Academic Article
|
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
|
Academic Article
|
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
Academic Article
|
Increased injection number enhances adenoviral genetic radiotherapy.
|
Academic Article
|
The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines.
|
Academic Article
|
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
|
Academic Article
|
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
|
Academic Article
|
Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.
|
Academic Article
|
Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
|
Academic Article
|
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors.
|
Academic Article
|
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
|
Academic Article
|
Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines.
|
Academic Article
|
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas.
|
Academic Article
|
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
|
Academic Article
|
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
|
Academic Article
|
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene.
|
Academic Article
|
Radiation-induced DNA double-strand break frequencies in human squamous cell carcinoma cell lines of different radiation sensitivities.
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
Academic Article
|
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
Academic Article
|
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
|
Academic Article
|
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
|
Academic Article
|
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
|
Academic Article
|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
|
Academic Article
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
|
Academic Article
|
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
|
Academic Article
|
More on cetuximab in head and neck cancer.
|
Academic Article
|
Prediction of the radiation sensitivity of human squamous cell carcinoma cells using DNA filter elution.
|
Academic Article
|
Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
|
Academic Article
|
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas.
|
Academic Article
|
Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma.
|
Academic Article
|
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
|
Academic Article
|
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
|
Academic Article
|
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas.
|
Academic Article
|
Radioresistant tumor cell lines derived from head and neck radiation failures.
|
Academic Article
|
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines.
|
Academic Article
|
Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones.
|
Academic Article
|
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
|
Academic Article
|
The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neck.
|
Academic Article
|
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
|
Academic Article
|
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.
|
Academic Article
|
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
|
Academic Article
|
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
|
Academic Article
|
Multidisciplinary treatment of advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells.
|
Academic Article
|
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
|
Academic Article
|
An aggressive approach to marginally resectable lung cancer.
|
Academic Article
|
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
|
Academic Article
|
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
|
Academic Article
|
An epidermoid carcinoma cell line derived from hamster 7,12-dimethylbenz[a]anthracene-induced buccal pouch tumors.
|
Academic Article
|
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
|
Academic Article
|
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
|
Academic Article
|
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
|
Academic Article
|
The differential diagnosis of the mass in the neck. A fresh look.
|
Academic Article
|
Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation.
|
Academic Article
|
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
|
Academic Article
|
X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines.
|
Academic Article
|
Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines.
|
Academic Article
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
|
Academic Article
|
The role of chemotherapy for advanced carcinoma of the supraglottic and glottic larynx.
|
Academic Article
|
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer.
|
Academic Article
|
Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy.
|
Academic Article
|
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
|
Academic Article
|
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
|
Academic Article
|
Chemical modulation of the hypoxic fraction in the treatment of head and neck cancer.
|
Academic Article
|
Clonal interactions in a human squamous cell carcinoma.
|
Academic Article
|
Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.
|
Academic Article
|
Surgical management of the head and neck cancer patient following concomitant multimodality therapy.
|
Academic Article
|
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.
|
Academic Article
|
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy.
|
Academic Article
|
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
|
Academic Article
|
The characteristics of long-term survivors of lung cancer treated with radiation.
|
Academic Article
|
Chemotherapy for advanced carcinoma of the head and neck. A clinical update.
|
Academic Article
|
Growth and magnetic resonance characteristics of human squamous cell carcinoma xenografts implanted with cells suspended in Matrigel.
|
Academic Article
|
Radiotherapy of the resected mandible following stainless steel plate fixation.
|
Academic Article
|
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
|
Academic Article
|
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
|
Academic Article
|
Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
|
Academic Article
|
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
|
Academic Article
|
The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.
|
Academic Article
|
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
|
Academic Article
|
Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems.
|
Academic Article
|
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
|
Academic Article
|
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
|
Academic Article
|
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
|
Academic Article
|
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
|
Academic Article
|
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
|
Academic Article
|
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
|
Academic Article
|
Racial parities in outcomes after radiotherapy for head and neck cancer.
|
Academic Article
|
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.
|
Academic Article
|
Survival outcomes for postoperative chemoradiation in intermediate-risk oral tongue cancers.
|
Academic Article
|
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
|
Academic Article
|
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
|